title: Mepolizumab (Nucala) for severe eosinophilic asthma.
mesh_terms: D000818:Animals; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics / Q000276:immunology; D016527:Drug Costs; D005260:Female; D006801:Humans; D011247:Pregnancy; D011657:Pulmonary Eosinophilia / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics / Q000276:immunology; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D018927:Anti-Asthmatic Agents; D061067:Antibodies, Monoclonal, Humanized; C434107:mepolizumab